Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity

Pistelli R., Lange P., Miller D.L.

Source: Eur Respir J 2003; 21: 10S-14S
Journal Issue: May 2003 - Suppl. 40
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pistelli R., Lange P., Miller D.L.. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J 2003; 21: 10S-14S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009

Asthma in the elderly
Source: Eur Respir Mon; 2009: 43: 56–76
Year: 2009

Socioeconomic risk factors for COPD and respiratory symptoms in a general population
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Infection and comorbidity
Source: Eur Respir Mon 2013; 59: 64-79
Year: 2013


Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006



The impact of airway infection on cardiovascular risk during COPD exacerbations
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012

Mechanisms of exacerbation of respiratory symptoms in patients with CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Prevalence and risk factors of airflow obstruction in an elderly Chinese population
Source: Eur Respir J 2008; 32: 1472-1478
Year: 2008



LATE-BREAKING ABSTRACT: The impact of comorbidities on all-cause mortality among subjects with and without airway obstruction
Source: International Congress 2016 – Important factors, besides smoking, that relate to lung function and decline in lung function
Year: 2016


Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

COPD coronary/peripheral vascular disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Effect of different asthma treatments on risk of cold-related exacerbations
Source: Eur Respir J 2011; 38: 584-593
Year: 2011



Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007



Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015

Malnutrition influences exacerbations and airways bacterial colonization in COPD patients with chronic respiratory failure
Source: Eur Respir J 2003; 22: Suppl. 45, 540s
Year: 2003

Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016